Clinical trial
Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145689 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-Term Study of OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- August 31, 2014
- Completion date
- May 31, 2017
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.